hydroxyproline has been researched along with everolimus in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chambers, RC; Egan, JJ; Goldsack, NR; Hasleton, PS; Howell, DC; Laurent, GJ; Marshall, RP; Simler, NR | 1 |
| Beckert, S; Coerper, S; Königsrainer, A; Küper, MA; Mayer, P; Schölzl, N; Steurer, W; Traub, F; Weinreich, J | 1 |
| de Man, BM; Hendriks, T; Lomme, RM; van der Vliet, JA; Willems, MC | 1 |
| Bridle, KR; Campbell, CM; Clouston, AD; Crawford, DH; de Guzman, CE; Jaskowski, LA; Nathan Subramaniam, V; Santrampurwala, N; Sobbe, AL | 1 |
| Beckert, S; Königsrainer, A; Küper, MA; Trütschel, S; Weinreich, J | 1 |
| Akdur, A; Haberal, M; Karakaya, E; Ok Atilgan, A; Ozturan Ozer, HE; Uysal, AC; Yildirim, S | 1 |
6 other study(ies) available for hydroxyproline and everolimus
| Article | Year |
|---|---|
The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats.
Topics: Animals; Antimetabolites, Antineoplastic; Bleomycin; Collagen; Everolimus; Hydroxyproline; Immunosuppressive Agents; Lung; Male; Organ Size; Pulmonary Fibrosis; Rats; Rats, Inbred Lew; Sirolimus; Spleen | 2002 |
Everolimus interferes with the inflammatory phase of healing in experimental colonic anastomoses.
Topics: Anastomosis, Surgical; Animals; Colon; Everolimus; Hydroxyproline; Immunosuppressive Agents; Inflammation; Interleukin-6; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Models, Animal; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Sirolimus; TOR Serine-Threonine Kinases; Wound Healing | 2011 |
Everolimus-induced loss of wound strength can be prevented by a short postoperative delay in its administration.
Topics: Administration, Oral; Anastomosis, Surgical; Animals; Collagen; Colon; Drug Administration Schedule; Everolimus; Hydroxyproline; Ileum; Immunosuppressive Agents; In Vitro Techniques; Laparotomy; Male; Postoperative Period; Rats; Rats, Wistar; Sirolimus; Tensile Strength; TOR Serine-Threonine Kinases; Wound Healing | 2011 |
Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2⁻/⁻ mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Biphenyl Compounds; Captopril; Drug Therapy, Combination; Everolimus; Female; Gene Expression Regulation; Hydroxyproline; Irbesartan; Liver; Liver Cirrhosis, Experimental; Male; Mice, Knockout; Protein Kinase Inhibitors; Renin-Angiotensin System; Signal Transduction; Sirolimus; Species Specificity; Tetrazoles; Time Factors; TOR Serine-Threonine Kinases | 2015 |
Growth hormone abolishes the negative effects of everolimus on intestinal wound healing.
Topics: Anastomosis, Surgical; Animals; Everolimus; Human Growth Hormone; Hydroxyproline; Intestines; Male; Peroxidase; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; TOR Serine-Threonine Kinases; Wound Healing | 2016 |
Effect of Adipose-Derived Stem Cells on Colonic Anastomosis in Rats Immunosuppressed With Everolimus: An Experimental Study.
Topics: Adipose Tissue; Anastomosis, Surgical; Animals; Colon; Everolimus; Hydroxyproline; Immunosuppression Therapy; Male; Rats; Rats, Sprague-Dawley; Stem Cells; Treatment Outcome | 2021 |